Small Coronary Vessel Size: A Great Need for a Standardized Definition

Overview

Journal J Soc Cardiovasc Angiogr Interv

Specialty Cardiology & Vascular Diseases

Date 2024 Aug 12

PMID 39131482

Authors

J J Coughlan

Adnan Kastrati

Affiliations

Soon will be listed here.

References

Megaly M, Buda K, Saad M, Tawadros M, Elbadawi A, Basir M . Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease. Cardiovasc Revasc Med. 2021; 35:76-82. DOI: 10.1016/j.carrev.2021.03.008. View

Koskinas K, Nakamura M, Raber L, Colleran R, Kadota K, Capodanno D . Current use of intracoronary imaging in interventional practice - Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical.... EuroIntervention. 2018; 14(4):e475-e484. DOI: 10.4244/EIJY18M03_01. View

von Birgelen C, Sen H, Lam M, Danse P, Jessurun G, Hautvast R . Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial. Lancet. 2013; 383(9915):413-23. DOI: 10.1016/S0140-6736(13)62037-1. View

Kitahara H, Okada K, Kimura T, Yock P, Lansky A, Popma J . Impact of Stent Size Selection on Acute and Long-Term Outcomes After Drug-Eluting Stent Implantation in De Novo Coronary Lesions. Circ Cardiovasc Interv. 2017; 10(10). DOI: 10.1161/CIRCINTERVENTIONS.116.004795. View

Jeger R, Farah A, Ohlow M, Mangner N, Mobius-Winkler S, Leibundgut G . Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet. 2018; 392(10150):849-856. DOI: 10.1016/S0140-6736(18)31719-7. View

Murai T, van de Hoef T, van den Boogert T, Wijntjens G, Stegehuis V, Echavarria-Pinto M . Quantification of Myocardial Mass Subtended by a Coronary Stenosis Using Intracoronary Physiology. Circ Cardiovasc Interv. 2019; 12(8):e007322. DOI: 10.1161/CIRCINTERVENTIONS.118.007322. View

Finet G, Gilard M, Perrenot B, Rioufol G, Motreff P, Gavit L . Fractal geometry of arterial coronary bifurcations: a quantitative coronary angiography and intravascular ultrasound analysis. EuroIntervention. 2009; 3(4):490-8. DOI: 10.4244/eijv3i4a87. View

Sanz Sanchez J, Chiarito M, Cortese B, Moretti A, Pagnotta P, Reimers B . Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2020; 98(1):66-75. DOI: 10.1002/ccd.29111. View

van der Heijden L, Kok M, Danse P, Schramm A, Hartmann M, Lowik M . Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial. Am Heart J. 2016; 176:28-35. DOI: 10.1016/j.ahj.2016.02.020. View

10.

Dodge Jr J, Brown B, Bolson E, DODGE H . Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation. 1992; 86(1):232-46. DOI: 10.1161/01.cir.86.1.232. View

11.

Cortese B, di Palma G, Garcia Guimaraes M, Piraino D, Orrego P, Buccheri D . Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial. JACC Cardiovasc Interv. 2020; 13(24):2840-2849. DOI: 10.1016/j.jcin.2020.08.035. View